Medical Oncology at Penn State Hershey Cancer Institute
Oncology
Dr. Nelson S. Yee, MD
|
|
Give Review
Nelson works in the field of Oncology. He researched medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18/49 in Research/PrimaryCare. Nelson is a published physician as well. He has 29 publications published. The latest was: Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis.
- Translating Discovery in Zebrafish Pancreatic Development to Human Pancreatic Cancer: Biomarkers, Targets, Pathogenesis, and Therapeutics.
- Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
- Transient receptor potential ion channel TRPM7 is required for preventing replicative senescence in pancreatic adenocarcinoma cells.
- Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targeting.
- Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer.
- Pancreatic Adenocarcinoma Associated With Werner's Syndrome (Adult-Onset Progeria).
- Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.
- Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
- Mutation of RNA Pol III subunit rpc2/polr3b Leads to Deficiency of Subunit Rpc11 and disrupts zebrafish digestive development.
- Clinical remission of acquired thrombasthenia with low-dose methotrexate in a patient with systemic lupus erythematosus.
- Exocrine pancreas development in zebrafish.
- Zebrafish as a model for pancreatic cancer research.
- Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas.
- Clinicopathologic and molecular features of pancreatic adenocarcinoma associated with Peutz-Jeghers syndrome.
- Ischemic colitis associated with anti-beta2 glycoprotein-I antibody.
- Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion.
- EDITORIAL: Advances in Pharmacological Treatment of Cancer in Digestive Organs.
- Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma.
- Aberrantly Over-Expressed TRPM8 Channels in Pancreatic Adenocarcinoma: Correlation with Tumor Size/Stage and Requirement for Cancer Cells Invasion.
- Ectopic expression of a c-kitW42 minigene in transgenic mice: recapitulation of W phenotypes and evidence for c-kit function in melanoblast progenitors.
- Se(VI) reduction and the precipitation of Se(0) by the facultative bacterium Enterobacter cloacae SLD1a-1 are regulated by FNR.
- Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice.
- Ischemic colitis associated with decongestant use.
- Ischemic colitis associated with factor V Leiden mutation.
- Zebrafish pdx1 morphant displays defects in pancreas development and digestive organ chirality, and potentially identifies a multipotent pancreas progenitor cell.
- Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma.
- Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer.
Schools
Weill Cornell Medical College
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Capital Blue Cross
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Gateway Health Plan
- Geisinger Health Plan
- Community Blue PPO
- Humana
- Medicaid
- Medicare MCR
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC Health Plan
Education
-
University of Pennsylvania Health System -
Weill Cornell Medical College of Cornell University
Hospital
-
Penn State Milton S. Hershey Medical Center
Drug Facts
| NPI NUMBER | 1659388999 | |
| NPPES Provider LastName | YEE | |
| NPPES Provider FirstName | NELSON | |
| NPPES Provider ZIPCode | 170332360 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 514.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 83.0 | |
| Percent Opioid Claims | 16.15 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659388999 |
| Last Name Of The Provider | YEE |
| First Name Of The Provider | NELSON |
| View All |
Similar Doctors
|
|
Dr. Philip A. Masters, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil D. Palmisiano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen F. Hennrikus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Stepp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher N. Sciamanna, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amit Barochia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Flood Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Gunther, MD
This Doctor is OpenDoctor Recommended.
|